Analyst Ratings for Amylyx Pharmaceuticals inc. (AMLX)
AMLX Rating Summary
AMLX Price Target Summary
- Highest: $57.00 (Guggenheim)
- Lowest: $20.00 (Citi)
- Average: $38.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.43 (+13.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$38.43 (+13.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Stifel | James Condulis | New Coverage | Buy (N/A) |
21.00 (N/A) |
15.17 (33.81) |
122.87% | Details |
| 7/10/2025 | Goldman Sachs » Updated 8/27/2025 |
Corinne Johnson | New Coverage | Buy (N/A) |
10.00 (N/A) |
6.98 (33.81) |
384.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
